New combination drug therapy proves very effective in Hepatitis C treatmentsMedical XpressAfter exposure 80 percent of patients develop a chronic hepatitis which can lead to cirrhosis, liver failure and liver cancer and hepatitis C is the most common c…
Can't compare Khan's words with Shah's: Mulayam – Times of India
Times of India |
Can’t compare Khan’s words with Shah’s: Mulayam
Times of India Similarly, all medicines would be free and treatment of patients suffering from cancer, lung, liver and heart diseases would also be borne by our government. We would even give interest free loans to farmers,” he said while appealing to the people to … |
No staple cure – Mumbai Mirror
No staple cureMumbai MirrorLast fortnight, Mumbai banker Gopal Agarwal moved the Maharashtra Medical Council against three leading doctors at Nova Surgery Specialty in Tardeo. His 56-year-old father, Puranchand, died last year following lung complicati…
More than 100 respond to Naim's blood donation drive – The Borneo Post
|
More than 100 respond to Naim’s blood donation drive
The Borneo Post KUCHING: Naim Holdings Bhd held its ‘Donate Blood, Save a Life’ group blood donation drive simultaneously in Miri, Bintulu and here yesterday. More than 100 donors turned up at the three venues of the campaign – Naim’s Kuching Sales Gallery, Naim … |
Three little girls with cancer inspire thousands with their message of hope – MorungExpress
Three little girls with cancer inspire thousands with their message of hopeMorungExpressThe cause is particular poignant for Ms Scantling, whose stepfather Larry is fighting off stage 4 lung cancer. Her close friend also lost her one-year-old to leukem…
New Combination Drug Therapy Proves Very Effective In Hepatitis C Treatments – Newswise (press release)
New Combination Drug Therapy Proves Very Effective In Hepatitis C TreatmentsNewswise (press release)After exposure 80 percent of patients develop a chronic hepatitis which can lead to cirrhosis, liver failure and liver cancer and hepatitis C is the mos…
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir … – MarketWatch
The Pharma Letter |
Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir …
MarketWatch In Europe it is a leading cause of liver transplantation.7. The World Health Organisation (WHO) and the European Association for the Study of the Liver (EASL) estimate that 150 million people worldwide were chronically infected with HCV in 2011.8 The … New data reveals positive outcomes for hepatitis C transplant patientsEureka! Science News Sovaldi Continues to Excel in Trials with Hep C, Advanced Liver DiseaseDrug Discovery & Development |
Large Study Sheds New Light On Tissue-Type Mismatches And Their Impact On … – The MDS Beacon
Large Study Sheds New Light On Tissue-Type Mismatches And Their Impact On …The MDS BeaconA simple analogy can be helpful for better understanding the difference between low-resolution and high-resolution HLA typing. In particular, think of HLA-relate…
New advances in HCC diagnosis, staging and treatment all predicted to improve … – Medical Xpress
New advances in HCC diagnosis, staging and treatment all predicted to improve …Medical XpressIn Japanese patients, 59% were within the Milan Criteria (generally accepted set of parameters designed to assess the suitability of HCC patients for liver t…
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial … – PR Web (press release)
|
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial …
PR Web (press release) Today the latest results and research progress of the prospective INSPIRE trial, initiated in late 2011, will be announced at the International Society for Heart and Lung Transplantation’s 34th Annual Meeting and Scientific Sessions. The presentation … |